Our Research Priorities
Drive Strategic Investments
May 25, 2017
The 13th International Conference on Alzheimer's and Parkinson's Diseases and Related Neurological Disorders took place in March 2017, with speakers including MJFF's Jamie Eberling, PhD.
May 17, 2017
Analysis of data from the MJFF-sponsored Parkinson's Progression Markers Initiative gives window into how and why cognitive problems develop in PD
UPCOMING FUNDING PROGRAM DEADLINES
Deadline: Pre-Proposals Due: October 19, 2016 - 5pm US ET
Part of our Edmond J. Safra Core Programs for PD Research, the Therapeutic Pipeline Program supports Parkinson's disease therapeutic development along the pre-clinical and clinical path (both drug and non-pharmacological therapeutics, including gene therapy, biological, surgical and non-invasive approaches).
Deadline: We are no longer accepting pre-proposals at this time.
Part of our Edmond J. Safra Core Programs for PD Research, the Target Advancement program seeks to build robust evidence to rationalize biological pathways and targets for further translation into new Parkinson's treatments.